Mumbai, India
Chempro Pharma Pvt. Ltd., founded in 2008 and headquartered in India, positions itself as a frontrunner in the pharmaceutical industry with a strong emphasis on contract manufacturing and export of a diverse range of products, including API, Intermediates, KSM, Impurities, Pellets, FDF, Biosimilars, and Nutraceuticals. With the slogan "Superior Quality | Higher Affordability | Reliable Service," the company is dedicated to providing exceptional value and service to its global partners.
Operating in over 70 countries across Asia, Europe, Africa, and the Americas, Chempro has built its reputation on quality and reliability, supported by a comprehensive network of globally compliant facilities adhering to standards such as WHO, EUGMP, USFDA, MFDS, and PMDA. Crucially, the firm offers end-to-end solutions, leveraging innovative R&D through partnerships with top scientific institutions in India, which ensures cost-efficient, rapid product development.
Chempro's extensive experience and strategic capabilities make it a valuable partner, providing robust support in process development, technology transfers, and regulatory affairs. Their notable focus on frugal innovation and sustainability drives reliable value chain solutions, appealing to investors looking for stability and growth in the healthcare sector. Despite no recent investment reported, the company remains a significant entity with profound industry expertise.
